UNITED THERAPEUTICS Corp (UTHR)
UNITED THERAPEUTICS Corp (UTHR) from its SEC filings: 2025 revenue $3.2 billion (+11% vs the year before), net margin 42%, free cash flow $1.0 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Revenue (2025) | $3.2 billion |
| Revenue growth | +11% |
| Net income | $1.3 billion |
| Net margin | 41.9% |
| Free cash flow | $1.0 billion |
| Diluted EPS | $27.86 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -2% |
| Cash | $1.8 billion |
| Share count, 1 year | -5% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.